Hepatocyte Growth Factor and Insulin-like Growth Factor-1 Based Cellu-lar Therapies for Oxidative Stress Injury


ŞAHAN Ö. B. , ÖZCAN A.

CURRENT STEM CELL RESEARCH & THERAPY, vol.16, no.7, pp.771-791, 2021 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Review
  • Volume: 16 Issue: 7
  • Publication Date: 2021
  • Doi Number: 10.2174/1574888x16999201124153753
  • Journal Name: CURRENT STEM CELL RESEARCH & THERAPY
  • Journal Indexes: Science Citation Index Expanded, Scopus, BIOSIS, Biotechnology Research Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE
  • Page Numbers: pp.771-791
  • Keywords: Oxidative stress, reactive oxygen species, mesenchymal stem cells, preconditioning, insulin-like growth factor, hepatocyte growth factor, MESENCHYMAL STEM-CELLS, MET SIGNALING PATHWAY, FACTOR-SCATTER FACTOR, MARROW-DERIVED CELLS, HUMAN ADIPOSE-TISSUE, ACUTE-RENAL-FAILURE, RECEPTOR C-MET, FACTOR GENE, LIVER-CIRRHOSIS, FACTOR PROTECTS

Abstract

Imbalance between free radicals and antioxidants causes oxidative stress by the accumulation of reactive oxygen species (ROS) in the tissues and organs. Oxidative stress occurs in many damaged conditions, and the increase of ROS and reduction of antioxidants enhances inflammation, apoptosis, fibrosis and may worsen the pathology leading to organ failure. The potential therapies aim to increase antioxidants and decrease ROS. Mesenchymal stem cells (MSCs) isolated from the stroma of various tissues are multipotent cells and have beneficial effects on several diseases with their immunomodulation and regeneration capacities. MSCs trigger the proliferation of the cells with various secretory factors, reduce oxidative stress and decrease apoptosis, inflammation, fibrosis and thus, increase regeneration. However, survival, engraftment, and differentiation problems of transplanted MSCs restrict their protective and regenerative effects. Preconditioning of MSCs with several factors, such as cytokines, hypoxia, chemical agents, pharmacological drugs, physical factors and growth factors, enhances their repairing efficacy for injury and disease models. This review is mainly focused on insulin-like growth factor (IGF-1) and hepatocyte growth factor (HGF), and discusses the research on MSC priming/induction with IGF-1 and HGF stimulation either by supplementation or overexpression that can enhance the regenerative potential of MSCs on various oxidative stress conditions such as acute/chronic kidney diseases, lung injury, cancer, metabolic and cardiovascular diseases.